Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses

Author： Pickens Jennifer A.   Tripp Ralph A.  

Publisher： MDPI

E-ISSN： 1999-4915|10|1|48-48

ISSN： 1999-4915

Source： Viruses, Vol.10, Iss.1, 2018-01, pp. : 48-48

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targets for the Induction of Protective Immunity Against Influenza A Viruses

By Bodewes Rogier   Osterhaus Albert D.M.E.   Rimmelzwaan Guus F.  

Viruses, Vol. 2, Iss. 1, 2010-01 ,pp. : 166-189

MDPI

Access to resources Recommend Favorite

Innate Immunity to H5N1 Influenza Viruses in Humans

By Ramos Irene   Fernandez-Sesma Ana  

Viruses, Vol. 4, Iss. 12, 2012-11 ,pp. : 3363-3388

MDPI

Access to resources Recommend Favorite

NXT1, a Novel Influenza A NP Binding Protein, Promotes the Nuclear Export of NP via a CRM1-Dependent Pathway

By Chutiwitoonchai Nopporn   Aida Yoko  

Viruses, Vol. 8, Iss. 8, 2016-07 ,pp. : 209-209

MDPI

Access to resources Recommend Favorite

Rapid Detection and Differentiation of Swine-Origin Influenza A Virus (H1N1/2009) from Other Seasonal Influenza A Viruses

By Zhao Jiangqin   Wang Xue   Ragupathy Viswanath   Zhang Panhe   Tang Wei   Ye Zhiping   Eichelberger Maryna   Hewlett Indira  

Viruses, Vol. 4, Iss. 11, 2012-11 ,pp. : 3012-3019

MDPI

Access to resources Recommend Favorite

Unusual Influenza A Viruses in Bats

By Mehle Andrew  

Viruses, Vol. 6, Iss. 9, 2014-09 ,pp. : 3438-3449

MDPI

Access to resources Recommend Favorite